Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adult Glioma”

739 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 739 results

Testing effectiveness (Phase 2)Study completedNCT00012038
What this trial is testing

Chemotherapy in Treating Patients With Progressive or Recurrent Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
New Approaches to Brain Tumor Therapy Consortium
Testing effectiveness (Phase 2)Study completedNCT00062478
What this trial is testing

Study of Karenitecin (BNP1350) in Patients With Brain Tumors

Who this might be right for
Brain NeoplasmsMalignant Neoplasms, BrainBrain Tumors
BioNumerik Pharmaceuticals, Inc. 40
Testing effectiveness (Phase 2)WithdrawnNCT05218408
What this trial is testing

CYNK-001 IV and IC in Combination With IL2 in Surgical Eligible Recurrent GBM With IDH-1 Wild Type

Who this might be right for
Astrocytoma, Grade IVGlioblastomaGiant Cell Glioblastoma+1 more
Celularity Incorporated
Testing effectiveness (Phase 2)Study completedNCT00006268
What this trial is testing

Immunotoxin Therapy in Treating Patients With Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
New Approaches to Brain Tumor Therapy Consortium
Early research (Phase 1)Study completedNCT00019071
What this trial is testing

Chemotherapy Followed by Radiation Therapy in Treating Patients With Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT00014443
What this trial is testing

Topotecan and Thalidomide in Treating Patients With Recurrent or Refractory Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Rush University Medical Center 5
Not applicableLooking for participantsNCT02619890
What this trial is testing

Brain Glioma Registry Combining Clinical and Imaging Information

Who this might be right for
Adult Glioma
Asan Medical Center 9,000
Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Testing effectiveness (Phase 2)Study completedNCT01894061
What this trial is testing

NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more
Case Comprehensive Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT00003475
What this trial is testing

Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors

Who this might be right for
Malignant Brain Tumors
Burzynski Research Institute 40
Testing effectiveness (Phase 2)Ended earlyNCT03352427
What this trial is testing

Study of Dasatinib in Combination With Everolimus for Children and Young Adults With Gliomas Harboring Platelet-Derived Growth Factor Receptor (PDGFR) Alterations

Who this might be right for
GliomaHigh Grade GliomaPontine Tumors
University of Michigan Rogel Cancer Center 3
Testing effectiveness (Phase 2)Study completedNCT00025675
What this trial is testing

Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 105
Testing effectiveness (Phase 2)Study completedNCT01806675
What this trial is testing

18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+41 more
Sanjiv Sam Gambhir 25
Very early researchEnded earlyNCT04825275
What this trial is testing

Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: A Phase 0 Clinical Trial

Who this might be right for
GlioblastomaGlioblastoma MultiformeGlioblastoma Multiforme of Brain+1 more
Milton S. Hershey Medical Center 7
Early research (Phase 1)Study completedNCT01644955
What this trial is testing

Carboplatin in Treating Patients With Recurrent High-Grade Gliomas

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaRecurrent Adult Brain Tumor
James Elder 10
Not applicableStudy completedNCT01342757
What this trial is testing

Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma

Who this might be right for
Adult GlioblastomaDepressionRecurrent Adult Brain Tumor
National Cancer Institute (NCI) 12
Not applicableLooking for participantsNCT07242963
What this trial is testing

Relapsed and Progressive Sonic Hedgehog Medulloblastoma With U1 Mutation Registry Study

Who this might be right for
Medulloblastoma RecurrentMedulloblastoma, Childhood, RecurrentMedulloblastoma, SHH-activated and TP53 Mutant+1 more
Mohammad H. Abu Arja 300
Early research (Phase 1)Study completedNCT00019019
What this trial is testing

Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerKidney Cancer+6 more
National Institutes of Health Clinical Center (CC) 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT02494804
What this trial is testing

Effect of Cytokine-induced Killer Cells for Stage I-II Malignant Gliomas

Who this might be right for
Cytokine-Induced Killer CellsMilignant Gliomas
The First People's Hospital of Changzhou 80
Early research (Phase 1)Study completedNCT01043536
What this trial is testing

Dose Escalation Radiotherapy With Modulation of Intensity and Integrated Boost (SIB-IMRT) in the Treatment of Glioblastomas in Adults

Who this might be right for
Glioblastoma
Centre Georges Francois Leclerc 10
Load More Results